What if you'd held NMTC?
A $1,000 investment in NeuroOne Medical Technologies Corporation (NMTC) at the month-end close of 2018-03 would be worth $31.79 at the close of 2026-08 — -96.8% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $2,919.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2018
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2018 | $1,000 | — |
| 2019 | $428 | -57.2% |
| 2020 | $282 | -34.0% |
| 2021 | $116 | -58.8% |
| 2022 | $71.94 | -38.1% |
| 2023 | $94.72 | +31.7% |
| 2024 | $49.56 | -47.7% |
| 2025 | $45.46 | -8.3% |
| 2026 | $21.78 | -52.1% |
Best and worst month-end to buy
The best single month-end close to have bought NMTC was 2026-07 ($1.70): $1,000 then is $1,282 today. The worst was 2019-02 ($108): $1,000 then is $20.19.
FAQ
What would $1,000 in NMTC be worth today?
A $1,000 investment in NeuroOne Medical Technologies Corporation (NMTC) at the start of 2018 would be worth about $31.79 today, a total return of -96.8%. Dividends are reinvested in these figures.
What were the best and worst years for NMTC?
NeuroOne Medical Technologies Corporation (NMTC)'s strongest calendar year since 2018 was 2023, a +31.7% return — $1,000 held through that year became about $1,317 by year-end. Its weakest year was 2021, at -58.8%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in NMTC have grown?
Investing $100 at the end of every month since 2018-03 would have grown to about $2,573 on $10,200 invested.
Did NMTC beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $2,919. NMTC trailed the S&P 500 by +98.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
NeuroOne Medical Technologies Corporation (NMTC) historical total-return data from 2018-03 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.